Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes - PubMed (original) (raw)
Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes
D Rosenbaum et al. Am J Physiol. 1993 Feb.
Abstract
We have found that women with polycystic ovary syndrome (PCOS) have decreased sensitivity and responsiveness to insulin. The present study was performed to determine whether this impaired insulin responsiveness was associated with diminished GLUT-4 glucose transporter content in adipocytes. Insulin-stimulated glucose transport and GLUT-4 abundance were measured in abdominal adipocytes from obese (n = 9) and lean (n = 7) PCOS as well as obese (n = 8) and lean (n = 8) control women matched for age and weight. No woman had impaired glucose tolerance. The maximal insulin-stimulated increment in adipocyte glucose transport was independently decreased by obesity and by PCOS. As expected, GLUT-4 content in adipocyte membranes was decreased in obesity (by 40%, P < or = 0.01). GLUT-4 content was also significantly decreased in PCOS (by 36%, P < or = 0.01), independent of obesity. There was a highly significant correlation (R = 0.66, P < = 0.001) between GLUT-4 content and insulin-stimulated glucose transport in adipocytes from individual women across the study population. We conclude that the diminished adipocyte insulin responsiveness in PCOS is associated with decreased GLUT-4 abundance. This represents a newly recognized phenotypic feature of the insulin resistance of PCOS. Moreover, in human adipocytes, GLUT-4 abundance is highly correlated with insulin responsiveness.
Similar articles
- Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP. Garvey WT, et al. J Clin Invest. 1991 Mar;87(3):1072-81. doi: 10.1172/JCI115068. J Clin Invest. 1991. PMID: 1999488 Free PMC article. - Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR. Ciaraldi TP, et al. J Clin Endocrinol Metab. 2009 Jan;94(1):157-63. doi: 10.1210/jc.2008-1492. Epub 2008 Oct 14. J Clin Endocrinol Metab. 2009. PMID: 18854391 Free PMC article. - Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake.
Ezeh U, Chen IY, Chen YH, Azziz R. Ezeh U, et al. Clin Endocrinol (Oxf). 2019 Apr;90(4):542-552. doi: 10.1111/cen.13931. Epub 2019 Feb 14. Clin Endocrinol (Oxf). 2019. PMID: 30623452 Free PMC article. - Adipose tissue dysfunction in polycystic ovary syndrome.
Villa J, Pratley RE. Villa J, et al. Curr Diab Rep. 2011 Jun;11(3):179-84. doi: 10.1007/s11892-011-0189-8. Curr Diab Rep. 2011. PMID: 21424395 Review.
Cited by
- Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS.
Binder AK, Peecher DL, Qvigstad AJ, Gutierrez SD, Magaña J, Banks DB, Korach KS. Binder AK, et al. Endocrinology. 2023 Feb 11;164(4):bqad024. doi: 10.1210/endocr/bqad024. Endocrinology. 2023. PMID: 36718579 Free PMC article. - Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.
Jozkowiak M, Piotrowska-Kempisty H, Kobylarek D, Gorska N, Mozdziak P, Kempisty B, Rachon D, Spaczynski RZ. Jozkowiak M, et al. Cells. 2022 Dec 31;12(1):174. doi: 10.3390/cells12010174. Cells. 2022. PMID: 36611967 Free PMC article. Review. - The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome.
Akan OY, Bilgir O. Akan OY, et al. Rev Assoc Med Bras (1992). 2022 Jun 24;68(6):820-826. doi: 10.1590/1806-9282.20211215. eCollection 2022. Rev Assoc Med Bras (1992). 2022. PMID: 35766698 Free PMC article. - Developmental programming of insulin resistance: are androgens the culprits?
Puttabyatappa M, Sargis RM, Padmanabhan V. Puttabyatappa M, et al. J Endocrinol. 2020 Jun;245(3):R23-R48. doi: 10.1530/JOE-20-0044. J Endocrinol. 2020. PMID: 32240982 Free PMC article. Review. - Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective.
Dumesic DA, Abbott DH, Sanchita S, Chazenbalk GD. Dumesic DA, et al. Curr Opin Endocr Metab Res. 2020 Jun;12:41-48. doi: 10.1016/j.coemr.2020.02.013. Epub 2020 Mar 9. Curr Opin Endocr Metab Res. 2020. PMID: 32363240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials